The Holladay Journal is the local newspaper covering news and events in the city of Holladay, Utah. The Holladay Journal provides one of the best advertising channels to the residents of the city of Holladay. Holladayjournal.com is the online lead...

Holladay Journal | Educating | Entertaining | Informing

BigID

BigID Extends DSPM to Markdown Files, Closing a Critical Data Security Gap in the Age of Vibe Coding

Glancy Prongay Wolke &amp; Rotter LLP

Deadline Alert: ODDITY Tech Ltd. (ODD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke &amp; Rotter LLP About Securities Fraud Lawsuit

Info-Tech Research Group

AI and Future of Work Experts Dave Coplin and Felix Schmidt to Keynote at Info-Tech LIVE 2026 in Las Vegas

Law Offices of Howard G. Smith

DEADLINE ALERT for GEMI, PSIX, HTGC, LU: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Deadline Alert: Grocery Outlet Holding Corp. (GO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke &amp; Rotter LLP About Securities Fraud Lawsuit

IPX1031

IPX1031 Welcomes Teresa Fluegel as Vice President

Fluegel to focus on complex commercial 1031 Exchange transactions nationwide

Zealand Pharma

Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management

Deadline Alert: Alight, Inc. (ALIT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke &amp; Rotter LLP About Securities Fraud Lawsuit

New Alvarez & Marsal Spring 2026 Consumer Sentiment Report

New York, USA, April 29th, 2026, NewsDirect

PartyWoo

PartyWoo Launches Officially Licensed Baby Shark™ All-in-One Balloon Collection for the U.S. Celebration Market

Palmetto Publishing

Newly Released Self-Help Book From Fury to Freedom Empowers Readers to Break the Cycle of Anger and Build Healthier Live

Licensed counselor Charles Montgomery shares proven strategies for emotional control, communication, and lasting personal transformation, new from Palmetto Publishing!

Healthrise

Hospitals Face Mounting Margin Pressure as Reactive Revenue Cycles Put Financial Stability at Risk

Just Published! Bright Young Heroine Inspires Kids to Solve Problems and Build Empathy

Bright and inquisitive Mattie embarks on a problem-solving journey, showcasing resilience and creativity, just published by Palmetto Publishing.

Scaling.com

/C O R R E C T I O N -- Scaling.com/

The HON Company

HON Introduces Brim: A Sculpted Polyshell Chair Designed for Comfort and Versatility

International Motors, LLC

International Motors introduces My International, a connected digital ecosystem

DelveInsight Business Research LLP

Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsight

The metagenomics sequencing market is mainly fueled by the combined influence of several major factors. The growing prevalence of infectious diseases, including emerging and re-emerging pathogens, has heightened the demand for rapid and unbiased diagnostic solutions that can detect a broad spectrum of microorganisms without requiring prior assumptions. Simultaneously, ongoing advancements in next-generation sequencing (NGS) technologies, such as enhanced accuracy, faster turnaround times, and lower costs, have made metagenomic methods increasingly accessible and scalable for both clinical and research applications.

Therap Services

Therap Services Recognized in G2's 2026 Best Software Awards

IgA Nephropathy Market Forecast to 2036: Novel Therapies and Key Growth Drivers Fuel Expansion | DelveInsight

The IgAN market is growing due to rising prevalence, improved diagnostics, novel immunotherapies, ongoing clinical trials of therapies such as Zigakibart (Novartis), Sefaxersen (F. Hoffmann-La Roche/Ionis Pharmaceuticals), Povetacicept (Vertex Pharmaceuticals), ULTOMIRIS (AstraZeneca), Atacicept (Vera Therapeutics), Felzartamab (Biogen), TAK-079 (Takeda Pharmaceutical), WAL0921 (Walden Biosciences), ARO-C3 (Arrowhead Pharmaceuticals), and others, increased awareness, and strong R&amp;D investment, driving advances in treatment and early detection.